- Previous Close
1.880 - Open
1.760 - Bid 1.690 x --
- Ask 1.700 x --
- Day's Range
1.650 - 1.760 - 52 Week Range
1.640 - 5.050 - Volume
304,800 - Avg. Volume
620,094 - Market Cap (intraday)
225.334M - Beta (5Y Monthly) --
- PE Ratio (TTM)
7.68 - EPS (TTM)
0.220 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date May 27, 2025
- 1y Target Est
3.50
Herbs Generation Group Holdings Limited engages in the development, marketing, and sale of health supplements, cosmetics, and skincare products in Hong Kong. The company offers health supplements in the forms of pills, tablets, and liquids for immune system, metabolic syndrome, men's and women's health, and anti-ageing, as well as other health supplements. It also provides cosmetics and skincare products, such as serum, cream, mask, makeup remover, and facial cleanser; and health supplements for pets. The company sells its products under the Herbs, ZINO, Classic, Umeya, Energie, Men's INFiNiTY, Regal Green, and Herbs Pet brand names through health and beauty product chain retailers; non-chain retailers such as pharmacies and trading companies; retail stores; and e-commerce platform. Herbs Generation Group Holdings Limited was founded in 1999 and is headquartered in Kowloon, Hong Kong. Herbs Generation Group Holdings Limited operates as a subsidiary of Joy & Love Limited
www.herbs.hk--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2593.HK
View MorePerformance Overview: 2593.HK
Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2593.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2593.HK
View MoreValuation Measures
Market Cap
250.67M
Enterprise Value
254.38M
Trailing P/E
8.74
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.01
Price/Book (mrq)
3.68
Enterprise Value/Revenue
1.03
Enterprise Value/EBITDA
4.60
Financial Highlights
Profitability and Income Statement
Profit Margin
11.60%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
247.29M
Net Income Avi to Common (ttm)
28.69M
Diluted EPS (ttm)
0.220
Balance Sheet and Cash Flow
Total Cash (mrq)
33.63M
Total Debt/Equity (mrq)
44.42%
Levered Free Cash Flow (ttm)
--